Bio-Techne Corp Valuation
| TE1 Stock | 71.50 0.50 0.69% |
At this time, the firm appears to be fairly valued. Bio Techne Corp shows a prevailing Real Value of USD69.88 per share. The current price of the firm is USD71.5. Our model approximates the value of Bio Techne Corp from analyzing the firm fundamentals such as Price To Sales of 12.34 X, current valuation of 13.06 B, and EBITDA of 413.76 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Bio-Techne Corp's price fluctuation is very steady at this time. Calculation of the real value of Bio Techne Corp is based on 3 months time horizon. Increasing Bio-Techne Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Bio-Techne Corp's intrinsic value may or may not be the same as its current market price of 71.50, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 71.5 | Real 69.88 | Hype 72.0 | Naive 71.72 |
The intrinsic value of Bio-Techne Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bio-Techne Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bio Techne Corp helps investors to forecast how Bio-Techne stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bio-Techne Corp more accurately as focusing exclusively on Bio-Techne Corp's fundamentals will not take into account other important factors: Bio-Techne Corp Total Value Analysis
Bio Techne Corp is at this time anticipated to have takeover price of 13.06 B with market capitalization of 16.22 B, debt of 243.41 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bio-Techne Corp fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
13.06 B | 16.22 B | 243.41 M |
Bio-Techne Corp Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Bio-Techne implies not a very effective usage of assets in January.Bio-Techne Corp Profitability Analysis
The company reported the revenue of 1.11 B. Net Income was 272.05 M with profit before overhead, payroll, taxes, and interest of 0.About Bio-Techne Corp Valuation
The stock valuation mechanism determines Bio-Techne Corp's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Bio Techne Corp based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Bio-Techne Corp. We calculate exposure to Bio-Techne Corp's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bio-Techne Corp's related companies.8 Steps to conduct Bio-Techne Corp's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bio-Techne Corp's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bio-Techne Corp's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bio-Techne Corp's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bio-Techne Corp's revenue streams: Identify Bio-Techne Corp's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bio-Techne Corp's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bio-Techne Corp's growth potential: Evaluate Bio-Techne Corp's management, business model, and growth potential.
- Determine Bio-Techne Corp's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bio-Techne Corp's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Bio-Techne Stock Analysis
When running Bio-Techne Corp's price analysis, check to measure Bio-Techne Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio-Techne Corp is operating at the current time. Most of Bio-Techne Corp's value examination focuses on studying past and present price action to predict the probability of Bio-Techne Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio-Techne Corp's price. Additionally, you may evaluate how the addition of Bio-Techne Corp to your portfolios can decrease your overall portfolio volatility.